O6MeG also causes apoptosis by the mitochondrial pathway in p53-deficient glioma cells by decreasing the expression of Bcl-2 and activating caspase-9, suggesting that MGMT and p53 could play a role in the sensitivity to TMZ [200]. Here, TP53 is linked to central nervous system cancer.